ArticlePostepy w kardiologii interwencyjnej = Advances in interventional cardiology2026
Percutaneous closure of acquired Gerbode type I defect in adults: summary of a consecutive series of 7 cases.
Article in Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Gerbode defect (GD) is a rare anomaly: a left ventricle-to-right atrium shunt. Due to its infrequency, there are no treatment standards. Aim: We aimed to assess the feasibility, efficacy, and complications of transcatheter closure of acquired Gerbode defects in a consecutive series of adult patients. Material and methods: The single-center, prospective registry included all consecutive patients with iatrogenic GD treated via a transvenous approach using a steerable sheath and a telescopic system under 3D-RT TEE guidance between 2003 and 2025. Baseline, procedural, and follow-up data were analyzed. Results: We included 7 patients (3/7, 43% male) with a median age of 54.7 years (30-85 years). All patients presented with symptomatic right-sided heart failure (NYHA III, Conclusions: In this small series, transvenous closure of an acquired Gerbode defect using a steerable sheath and telescopic system under 3D-RT transesophageal echocardiography (TEE) was feasible in 5/7 patients. Larger studies with longer follow-up are needed to confirm the safety and efficacy of this approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.